Absci/ABSI

$5.83

-4.19%
-
1D1W1MYTD1YMAX

About Absci

Absci Corporation is a generative artificial intelligence (AI) drug creation company. The Company combines AI with scalable wet lab technologies to create biologics for patients. It has built an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. The Company uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and learn from the data it generates. Its SoluPro technology is a multiplex synthetic biology approach that overcomes the limitations of highest-throughput automation labs. The Company supports its generative AI designs with its wet lab's high-throughput functional validation capabilities. It reconstructs prevalent immune-response molecules, such as antibodies from disease tissue and identify their corresponding antigens, offering new therapeutic targets.

Ticker

ABSI

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Sean Mcclain

Employees

155

Headquarters

Vancouver, United States

Absci Metrics

BasicAdvanced
$657.53M
Market cap
-
P/E ratio
-$1.20
EPS
-
Beta
-
Dividend rate
$657.53M
$6.72
$1.11
1.54M
4.079
2.688
4.901
-93.25%
-41.08%
-49.08%
-46.22%
114.994
3.08
5.14
-0.5%
-4.02%
6.15%

What the Analysts think about Absci

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 5 analysts.
47.51% upside
High $13.00
Low $6.00
$5.83
Current price
$8.60
Average price target

Absci Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-7,833.33% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$300K
-57.14%
Net income
$-23.5M
7.31%
Profit margin
-7,833.33%
150.38%

Absci Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 3.25%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.26
-$0.45
-$0.24
-$0.25
-
Expected
-$0.24
-$0.24
-$0.23
-$0.25
-$0.21
Surprise
9.86%
84.43%
4.35%
3.25%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Absci stock?

Absci (ABSI) has a market cap of $657.53M as of April 14, 2024.

What is the P/E ratio for Absci stock?

The price to earnings (P/E) ratio for Absci (ABSI) stock is 0 as of April 14, 2024.

Does Absci stock pay dividends?

No, Absci (ABSI) stock does not pay dividends to its shareholders as of April 14, 2024.

When is the next Absci dividend payment date?

Absci (ABSI) stock does not pay dividends to its shareholders.

What is the beta indicator for Absci?

Absci (ABSI) does not currently have a Beta indicator.

What is the Absci stock price target?

The target price for Absci (ABSI) stock is $8.6, which is 47.51% above the current price of $5.83. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Absci stock

Buy or sell Absci stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing